According to the study’s abstract, periprostatic nerve block is the standard anesthesia for ultrasound-guided transrectal prostate biopsy, but periprostatic infiltration creates a major source of discomfort for patients. Non-infiltrative anesthesia therefore presents an attractive alternative to periprostatic infiltration.
The researchers aimed to determine the effectiveness and safety of perianal-interrectal lidocaine gel, lidocaine-ketorolac gel and lidocaine-prilocaine cream in relieving pain. Three-hundred consecutive patients scheduled for US-guided TPB were randomized to receive one of the treatments.
The study found that lidocaine-prilocaine cream was most effective on probe-related pain, whereas lidocaine-ketorolac gel was most effective on sampling-related pain.
Read the abstract in UroToday on the study on non-infiltrative anesthetics.
Read more on anesthesia:
–Capnography Could Reduce Airway Complications in Obese Anesthesia Patients
–Anesthesiology Residency Programs to Include Required Simulation Training
–University of Rochester’s Dr. Michael Eaton to Join Society of Cardiovascular Anesthesiologists Board
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
